Susquehanna International Group’s C4 Therapeutics CCCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.38M	Sell	1,286,840 -488,943	-28%	-$1.15M	﹤0.01%	5024
2025 Q4	$3.39M	Buy	1,775,783 +1,260,346	+245%	+$2.99M	﹤0.01%	4656
2025 Q3	$1.14M	Buy	515,437 +374,381	+265%	+$899K	﹤0.01%	7027
2025 Q2	$202K	Buy	141,056 +67,274	+91%	+$97.8K	﹤0.01%	11196
2025 Q1	$118K	Buy	73,782 +29,559	+67%	+$88.2K	﹤0.01%	11423
2024 Q4	$159K	Sell	44,223 -5,884	-12%	-$29.3K	﹤0.01%	10968
2024 Q3	$286K	Buy	50,107 +6,077	+14%	+$36.6K	﹤0.01%	9700
2024 Q2	$203K	Sell	44,030 -443,621	-91%	-$2.65M	﹤0.01%	10326
2024 Q1	$3.98M	Sell	487,651 -514,862	-51%	-$3.99M	﹤0.01%	4022
2023 Q4	$5.66M	Buy	1,002,513 +840,650	+519%	+$1.92M	﹤0.01%	3499
2023 Q3	$301K	Sell	161,863 -63,329	-28%	-$193K	﹤0.01%	9341
2023 Q2	$619K	Sell	225,192 -42,875	-16%	-$138K	﹤0.01%	7808
2023 Q1	$842K	Buy	268,067 +252,406	+1,612%	+$1.49M	﹤0.01%	7273
2022 Q4	$92.4K	Sell	15,661 -27,209	-63%	-$226K	﹤0.01%	11025
2022 Q3	$376K	Buy	+42,870	New	+$445K	﹤0.01%	9207
2022 Q2	–	Sell	-37,520	Closed	-$330K	–	12960
2022 Q1	$910K	Buy	37,520 +2,691	+8%	+$65.3K	﹤0.01%	7367
2021 Q4	$1.12M	Sell	34,829 -8,586	-20%	-$340K	﹤0.01%	6994
2021 Q3	$1.94M	Buy	43,415 +19,888	+85%	+$852K	﹤0.01%	5905
2021 Q2	$890K	Buy	23,527 +17,255	+275%	+$618K	﹤0.01%	8082
2021 Q1	$232K	Buy	+6,272	New	+$250K	﹤0.01%	11127